Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
Raghavendra Rao/LinkedIn
May 24, 2026, 03:33

Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy

Raghavendra Rao, General Surgeon at Vein Clinic, Founder of Best Surgical Education, LLC, shared a post on LinkedIn about a recent article by Maciej Wołkowski et al, published in JVS-VL, adding:

“Concomitant foam sclerotherapy of tributaries after truncal ablation with EVLA results in better varicose vein regression at 3 months in the short term and may result in a better quality of life at 6 months.

This comes at the cost of using too much or too concentrated sclerosant, resulting in foam sclerotherapy complications.

Non-randomized study published recently in JVS-VL.

The controversy continues regarding the need for tributary management after EVLA of the truncal veins, but a good percentage seem to need further treatments.

EVLA does have a substantial effect on tributary varicose veins.”

Title: Clinical trial of concomitant versus staged foam sclerotherapy of varicose veins following axial thermal ablation.

Authors: Maciej Wołkowski, Tomasz Urbanek, Krzysztof Wołkowski, Grzegorz Biolik, Wacław Kuczmik

Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy

Stay updated on all scientific advances with Hemostasis Today.

EVLA Grzegorz Biolik Health Hematology Hemostasis Hemostasis News Hemostasis Today JVS-VL Krzysztof Wołkowski Maciej Wołkowski Medicine Raghavendra Rao sclerotherapy Tomasz Urbanek Wacław Kuczmik
NewsFeed